Eutectic Formulations Of Cyclobenzaprine Hydrochloride And Amitriptyline Hydrochloride

Patent No. EP2968992 (titled "Eutectic Formulations Of Cyclobenzaprine Hydrochloride And Amitriptyline Hydrochloride") was filed by Tonix Pharma on Mar 14, 2014. The application was issued on Jan 15, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALSep 10, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2968992

TONIX PHARMA
Application Number
EP14762323A
Filing Date
Mar 14, 2014
Status
Opposition Rejected
Jul 8, 2022
Publication Date
Jan 15, 2020